Polyrizon (PLRZ) vs Picard Medical (PMI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Polyrizon (PLRZ) has outperformed Picard Medical (PMI) over the past year, gaining 23.2% versus a loss of 98.0%. Picard Medical is the larger company by market cap ($22.2 million vs $21.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PLRZ | PMI |
|---|---|---|
| Share price | $8.99 | $9.48 |
| Market cap | $21.83M | $22.17M |
| 1-day change | +1.33% | -2.07% |
| YTD return | +4.48% | -88.94% |
| 1-year return | +23.19% | -97.98% |
| EPS (TTM) | $-4.97 | $-6.93 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $18.20 | $684.00 |
| 52-week low | $2.88 | $2.65 |
| Distance from 52-week high | -50.61% | -98.61% |
| Average volume | 60.55K | 1.69M |
| Shares outstanding | 2.43M | 2.34M |
| Employees | 2 | 75 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PLRZ has outperformed PMI by 121.2 percentage points over the past year.
About Polyrizon
PLRZ stock →Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company uses its proprietary technology to develop its products comprising Capture and Contain, a barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients.
Health Care · Medical/Dental Instruments · 2 employees
About Picard Medical
PMI stock →Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure.
Health Care · Medical/Dental Instruments · 75 employees
PLRZ vs PMI FAQ
Which is bigger, Polyrizon or Picard Medical?
Picard Medical (PMI) is larger, with a market capitalization of $22.17M compared with $21.83M for Polyrizon (PLRZ).
Which stock has performed better over the past year, PLRZ or PMI?
PLRZ returned +23.19% over the past 12 months, compared with -97.98% for PMI (price return, excluding dividends). Past performance does not predict future results.
Are Polyrizon and Picard Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.